BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22437843)

  • 1. Biomimetic synthesis, antibacterial activity and structure-activity properties of the pyroglutamate core of oxazolomycin.
    Angelov P; Chau YK; Fryer PJ; Moloney MG; Thompson AL; Trippier PC
    Org Biomol Chem; 2012 May; 10(17):3472-85. PubMed ID: 22437843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxazolomycins: natural product lead structures for novel antibacterials by click fragment conjugation.
    Bagwell CL; Moloney MG; Yaqoob M
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2090-4. PubMed ID: 20223659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mimics of pramanicin derived from pyroglutamic acid and their antibacterial activity.
    Tan SW; Chai CL; Moloney MG
    Org Biomol Chem; 2017 Feb; 15(8):1889-1912. PubMed ID: 28169387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oxazolomycins: a structurally novel class of bioactive compounds.
    Moloney MG; Trippier PC; Yaqoob M; Wang Z
    Curr Drug Discov Technol; 2004 Oct; 1(3):181-99. PubMed ID: 16472256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of mimics of pramanicin from pyroglutamic acid and their antibacterial activity.
    Tan SW; Chai CL; Moloney MG; Thompson AL
    J Org Chem; 2015 Mar; 80(5):2661-75. PubMed ID: 25647715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicomponent coupling strategy suitable for the synthesis of the triene component of the oxazolomycin antibiotics.
    Bulger PG; Moloney MG; Trippier PC
    Org Biomol Chem; 2003 Nov; 1(21):3726-37. PubMed ID: 14649904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncatalysed diaryldiazo cyclopropanations on bicyclic lactams: access to annulated prolines.
    Harris L; Gilpin M; Thompson AL; Cowley AR; Moloney MG
    Org Biomol Chem; 2015 Jun; 13(23):6522-50. PubMed ID: 25975925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel triene-beta-lactone antibiotics, oxazolomycin derivative and its isomer, produced by Streptomyces sp. KSM-2690.
    Otani T; Yoshida KI; Kubota H; Kawai S; Ito S; Hori H; Ishiyama T; Oki T
    J Antibiot (Tokyo); 2000 Dec; 53(12):1397-400. PubMed ID: 11217805
    [No Abstract]   [Full Text] [Related]  

  • 9. Chiral bicyclic tetramates as non-planar templates for chemical library synthesis.
    Anwar M; Moloney MG
    Chem Biol Drug Des; 2013 May; 81(5):645-9. PubMed ID: 23350737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
    Arumugam N; Periyasami G; Raghunathan R; Kamalraj S; Muthumary J
    Eur J Med Chem; 2011 Feb; 46(2):600-7. PubMed ID: 21177001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and bioactivity of fused- and spiro-β-lactone-lactam systems.
    Josa-Culleré L; Towers C; Willenbrock F; Macaulay VM; Christensen KE; Moloney MG
    Org Biomol Chem; 2017 Jun; 15(25):5373-5379. PubMed ID: 28617490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective synthesis of pyroglutamate natural product analogs from α- aminoacids and their anti-cancer evaluation.
    Tekkam S; Alam MA; Just MJ; Berry SM; Johnson JL; Jonnalagadda SC; Mereddy VR
    Anticancer Agents Med Chem; 2013 Dec; 13(10):1514-30. PubMed ID: 23848201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of the pyrrolidinone core of KSM-2690 B.
    Donohoe TJ; Chiu JY; Thomas RE
    Org Lett; 2007 Feb; 9(3):421-4. PubMed ID: 17249777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterials. synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 4. Multiply-substituted aryl derivatives.
    Park CH; Brittelli DR; Wang CL; Marsh FD; Gregory WA; Wuonola MA; McRipley RJ; Eberly VS; Slee AM; Forbes M
    J Med Chem; 1992 Mar; 35(6):1156-65. PubMed ID: 1552508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric synthesis of the fully elaborated pyrrolidinone core of oxazolomycin A.
    Donohoe TJ; O'Riordan TJ; Peifer M; Jones CR; Miles TJ
    Org Lett; 2012 Nov; 14(21):5460-3. PubMed ID: 23061613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel bioactive oxazolomycin isomers produced by Streptomyces albus JA3453.
    Kanzaki H; Wada K; Nitoda T; Kawazu K
    Biosci Biotechnol Biochem; 1998 Mar; 62(3):438-42. PubMed ID: 9571773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of novel pleuromutilin derivatives with a substituted pyrimidine moiety.
    Yi Y; Yang G; Zhang C; Chen J; Liang J; Shang R
    Eur J Med Chem; 2015 Aug; 101():179-84. PubMed ID: 26134552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 1,3-oxazolo[4,5-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties.
    Eswaran S; Adhikari AV; Ajay Kumar R
    Eur J Med Chem; 2010 Mar; 45(3):957-66. PubMed ID: 20034708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselective, Organocatalytic Strategy for the Oxazolomycin Core: Formal Synthesis of (+)-Neooxazolomycin.
    Chaheine CM; Gladen PT; Abbasov ME; Romo D
    Org Lett; 2020 Dec; 22(23):9282-9286. PubMed ID: 33226820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxy tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of RHS moiety (Part-3).
    Singh SB; Kaelin DE; Wu J; Miesel L; Tan CM; Gill C; Black T; Nargund R; Meinke PT; Olsen DB; Lagrutta A; Wei C; Peng X; Wang X; Fukuda H; Kishii R; Takei M; Takeuchi T; Shibue T; Ohata K; Takano H; Ban S; Nishimura A; Fukuda Y
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2473-8. PubMed ID: 25978963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.